Literature DB >> 11105943

Tolerance to repeated nicotine administration on performance, subjective, and physiological responses in nonsmokers.

S J Heishman1, J E Henningfield.   

Abstract

RATIONALE: When administered acutely to nonsmokers, nicotine's effects on performance are inconsistent, perhaps because of suboptimal dosing or initial dysphoria that could interfere with performance.
OBJECTIVE: The purpose of this study was to determine if a range of nicotine doses administered for 8 days to nonsmokers would enhance psychomotor and cognitive abilities and to document the development of nicotine tolerance or sensitization.
METHODS: Twelve male volunteers, who reported ever smoking five cigarettes or less, participated in 8 consecutive experimental days in which they were administered four doses of nicotine polacrilex gum each day in this order: 0, 2, 4, and 8 mg. Performance, subjective, and physiological measures were assessed before and after each dose.
RESULTS: Plasma nicotine concentration ranged from 6.9 to 11.5 ng/ml following the 8 mg dose. Nicotine increased rate of responding and decreased response time on working memory (digit recall); however, accuracy was impaired. Nicotine also decreased accuracy on visual scanning and attention (two-letter search), and the 8 mg dose impaired gross motor coordination (circular lights). Tolerance did not develop to the performance impairing effects of nicotine. Nicotine produced dose-related increases in ratings of dysphoria and negative mood, including tension, anxiety, nervousness, turning of stomach, and sedation. Tolerance developed to some, but not all, of these aversive effects. Tolerance also was not observed to the increased cardiovascular measures.
CONCLUSION: Although tolerance developed to some of the aversive effects of nicotine, performance enhancement was not observed. These data do not support the hypothesis that nicotine-induced performance enhancement contributes to the reinforcing effects of tobacco use during the early stages of dependence development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11105943     DOI: 10.1007/s002130000541

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  The nicotinic acetylcholine receptor alpha5 subunit plays a key role in attention circuitry and accuracy.

Authors:  Craig D C Bailey; Mariella De Biasi; Paul J Fletcher; Evelyn K Lambe
Journal:  J Neurosci       Date:  2010-07-07       Impact factor: 6.167

2.  Nicotine reinforcement in never-smokers.

Authors:  Angela N Duke; Matthew W Johnson; Chad J Reissig; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2015-09-08       Impact factor: 4.530

3.  Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial.

Authors:  F Joseph McClernon; F Berry Hiott; Eric C Westman; Jed E Rose; Edward D Levin
Journal:  Psychopharmacology (Berl)       Date:  2006-09-15       Impact factor: 4.530

4.  Acute nicotine changes dynorphin and prodynorphin mRNA in the striatum.

Authors:  Raffaella Isola; Hailin Zhang; Gopi A Tejwani; Norton H Neff; Maria Hadjiconstantinou
Journal:  Psychopharmacology (Berl)       Date:  2008-09-21       Impact factor: 4.530

5.  Prompt but inefficient: nicotine differentially modulates discrete components of attention.

Authors:  Signe Vangkilde; Claus Bundesen; Jennifer T Coull
Journal:  Psychopharmacology (Berl)       Date:  2011-06-01       Impact factor: 4.530

6.  Acute effects of snus in never-tobacco users: a pilot study.

Authors:  Jenny E Ozga; Nicholas J Felicione; Daniel Elswick; Melissa D Blank
Journal:  Am J Drug Alcohol Abuse       Date:  2016-12-08       Impact factor: 3.829

7.  Nicotine differentially modulates antisaccade performance in healthy male non-smoking volunteers stratified for low and high accuracy.

Authors:  Nadine Petrovsky; Ulrich Ettinger; Boris B Quednow; Henrik Walter; Knut Schnell; Henrik Kessler; Rainald Mössner; Wolfgang Maier; Michael Wagner
Journal:  Psychopharmacology (Berl)       Date:  2011-10-29       Impact factor: 4.530

Review 8.  Nicotine and networks: Potential for enhancement of mood and cognition in late-life depression.

Authors:  Jason A Gandelman; Paul Newhouse; Warren D Taylor
Journal:  Neurosci Biobehav Rev       Date:  2017-08-30       Impact factor: 8.989

9.  Performance effects of nicotine during selective attention, divided attention, and simple stimulus detection: an fMRI study.

Authors:  Britta Hahn; Thomas J Ross; Frank A Wolkenberg; Diaa M Shakleya; Marilyn A Huestis; Elliot A Stein
Journal:  Cereb Cortex       Date:  2008-12-10       Impact factor: 5.357

10.  Nicotine increases initial blood flow responses to local heating of human non-glabrous skin.

Authors:  David O Warner; Michael J Joyner; Nisha Charkoudian
Journal:  J Physiol       Date:  2004-07-22       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.